Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-099193
Filing Date
2025-07-28
Accepted
2025-07-28 16:20:51
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mtsr-20250630.htm   iXBRL 10-Q 3130429
2 EX-10.1 mtsr-ex10_1.htm EX-10.1 610883
3 EX-10.2 mtsr-ex10_2.htm EX-10.2 61940
4 EX-31.1 mtsr-ex31_1.htm EX-31.1 17392
5 EX-31.2 mtsr-ex31_2.htm EX-31.2 17363
6 EX-32.1 mtsr-ex32_1.htm EX-32.1 10046
7 EX-32.2 mtsr-ex32_2.htm EX-32.2 10022
8 GRAPHIC img54170379_0.jpg GRAPHIC 362878
9 GRAPHIC img207383199_0.jpg GRAPHIC 18093
  Complete submission text file 0000950170-25-099193.txt   12603028

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mtsr-20250630.xsd EX-101.SCH 1338574
65 EXTRACTED XBRL INSTANCE DOCUMENT mtsr-20250630_htm.xml XML 1976476
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42489 | Film No.: 251155900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)